Concurrent Immunotherapy and Chemoradiation Under Study in Stage III NSCLC

Martin F. Dietrich, MD, PhD, discusses the significance of the PACIFIC trial on clinical practice and research efforts in stage III non–small cell lung cancer, expectations for ongoing clinical trials, and the emergence of targeted therapy in the adjuvant setting

Read the full article here

Related Articles